Sign Up Today and Learn More About DermBiont Stock
Invest in or calculate the value of your shares in DermBiont or other pre-IPO companies through EquityZen's platform.
DermBiont Stock (DERM)
DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.
About DermBiont Stock
Founded
2017
Headquarters
Boston, MA, US
Industries
Science and Engineering, Health Care, Biotechnology
DermBiont Press Mentions
Stay in the know about the latest news on DermBiont
Compositions and formulations for use of a pk inhibitor for the prevention, …
patents • Apr 15, 2024
Compositions and formulations for topical use of an akt inhibitor for the …
patents • Apr 15, 2024
Compositions and methods for improving skin health and for the treatment and …
patents • Apr 15, 2024
Human Microbiome Therapeutics Market Size and Share ...
prnewswire • Jan 24, 2024
Dermatology Market Size to Worth Around USD 3,140 Million ...
finance • Jan 24, 2024
DermBiont Management
Leadership team at DermBiont
Co-Founder, Chief Executive Officer, Chief Medical Officer
Karl Beutner
Co-Founder, Chief Scientific Officer
Robert Brucker
Join now and verify your accreditation status to gain access to:
- DermBiont current valuation
- DermBiont stock price
- Available deals in DermBiont and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading DermBiont Stock
How to invest in DermBiont stock?
Accredited investors can buy pre-IPO stock in companies like DermBiont through EquityZen funds. These investments are made available by existing DermBiont shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell DermBiont stock?
Shareholders can sell their DermBiont stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
